Allergan PLC is recalling almost 170,000 sample packs of its birth-control treatment Taytulla after placebo and active capsules were placed out of order, potentially raising the risk of an unintended pregnancy.
Drugmaker Allergan issued a voluntary recall for almost 170,000 birth control packs after it was revealed that a packaging error could cause unintended pregnancies.
The drugmaker said Tuesday the physician sample packs of Taytulla were created to have 24 active birth control pills, followed by four placebo pills, taken daily over the course of 28 days.
The Taytulla birth control pills being recalled were first issued August 27, 2017.
The packs contain 24 "active" pills with hormones, followed by four inactive, or placebo, pills that don't contain hormones. The placebo pills, which are meant to be placed at the end of a 28-pill pack, were mistakenly placed at the beginning of the pack.
The manufacturer is concerned that users of their contraceptive may not notice the reversed order, thereby increasing the possibility of an unintended pregnancy. Consumers who have those birth control pills should arrange to return them to their physicians. Allergan said that the incorrect order is significant enough to cause pregnancy. Recalled pills have the lot number 5620706 and expire in May 2019.
Allergan, the drug's manufacturer, announced the recall Tuesday.
Patients with concerns about unintended pregnancy should consult their doctor, the company said. The recall specifically affects the 6x28 physicians sample pack with Lot #5620706 (Exp 05/2019).